TALK - NASDAQ
Talkspace, Inc.
$5.21
-0.19%Talkspace, Inc. operates as a virtual behavior healthcare company. It delivers healthcare through encrypted web and mobile platform. The company offers treatment options for every need, including psychiatry or adolescent, individual, or couples therapy. The members can send text, video, and voice messages to their therapists and engage in live video sessions. Talkspace, Inc. is based in New York, New York.
At a Glance
Live Snapshottalk
Total Non-Current Assets
Last Annual Value
23.80M
3-Year CAGR
86%
5-Year CAGR
14%
10-Year CAGR
45%
Talkspace, Inc. Competitors Analysis of Total Non-Current Assets
| Company | Total Non-Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Talkspace, Inc. NASDAQ:TALK | 23.80M | 114.2% | 18.3% | N/A | |
 ClearPoint Neuro, Inc. NASDAQ:CLPT | 34.15M | 73.9% | 56.1% | 38.5% | |
 KalVista Pharmaceuticals, Inc. NASDAQ:KALV | 15.23M | 11.9% | 14.5% | 70.3% | |
 Sonida Senior Living, Inc. NYSE:SNDA | 766.97M | 9.2% | 4.3% | -3.2% | |
 InnovAge Holding Corp. NASDAQ:INNV | 381.12M | 0.6% | 5.8% | N/A | |
 Community Health Systems, Inc. NYSE:CYH | 9.97B | -3.9% | -3.2% | -5.4% | |
 Avanos Medical, Inc. NYSE:AVNS | 718.30M | -15.8% | -9.4% | -7.0% | |
 AirSculpt Technologies, Inc. NASDAQ:AIRS | 171.85M | -3.0% | 0.1% | N/A | |
 Rigel Pharmaceuticals, Inc. NASDAQ:RIGL | 273.43M | 147.8% | 84.3% | 64.2% |
Talkspace, Inc. Fair Value Envelope
Related Guides
Continue your TALK research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.